NGT HealthCare II
Overview
NGT HealthCare II is an early-stage venture capital fund based in Nazareth, Israel, focusing on medical device and life sciences technologies. The fund invests in promising technologies, leveraging significant non-dilutive leverage through Israel's Innovation Authority. NGT maintains close relationships with leading universities, hospitals, and research institutions in Israel, providing a rich flow of investment opportunities. The fund is structured as an impact fund, aligning with three United Nations Sustainable Development Goals. NGT's management team has led the establishment and investment in over 50 companies, including Prolor Biotech, Mazor Robotics, ReWalk, and Corindus. The team brings extensive experience in medical device and healthcare industries, with backgrounds in management, business development, and investor relations. NGT is committed to creating value and investing in people, aiming to expand its network and support innovative entrepreneurs in the medical device and life sciences sectors.
Investment Focus
- Innovative medical device and life sciences technologies
- Early-stage companies with high growth potential
- Alignment with UN Sustainable Development Goals
Portfolio Companies
Reach NGT HealthCare II directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about NGT HealthCare II
What sectors does NGT HealthCare II invest in?
NGT HealthCare II invests in Life Sciences and Medical Devices, and is based in Israel. NGT HealthCare II is listed as a venture capital in the ConnectSafely investor database.
What stage does NGT HealthCare II invest at?
NGT HealthCare II backs companies at Seed and Early Stage.
Which regions does NGT HealthCare II invest in?
NGT HealthCare II invests across Israel.
What companies has NGT HealthCare II invested in?
NGT HealthCare II's portfolio includes PROLOR Biotech, Corindus, Rewalk and Mazor Robotics.
Last updated · Source: ConnectSafely investor database